These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33174372)

  • 1. CD14 inhibition improves survival and attenuates thrombo-inflammation and cardiopulmonary dysfunction in a baboon model of Escherichia coli sepsis.
    Keshari RS; Silasi R; Popescu NI; Regmi G; Chaaban H; Lambris JD; Lupu C; Mollnes TE; Lupu F
    J Thromb Haemost; 2021 Feb; 19(2):429-443. PubMed ID: 33174372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.
    Thorgersen EB; Pharo A; Haverson K; Axelsen AK; Gaustad P; Kotwal GJ; Sfyroera G; Mollnes TE
    Infect Immun; 2009 Feb; 77(2):725-32. PubMed ID: 19047409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis.
    Keshari RS; Silasi R; Popescu NI; Georgescu C; Chaaban H; Lupu C; McCarty OJT; Esmon CT; Lupu F
    J Thromb Haemost; 2020 Jan; 18(1):180-190. PubMed ID: 31549765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs.
    Thorgersen EB; Hellerud BC; Nielsen EW; Barratt-Due A; Fure H; Lindstad JK; Pharo A; Fosse E; Tønnessen TI; Johansen HT; Castellheim A; Mollnes TE
    FASEB J; 2010 Mar; 24(3):712-22. PubMed ID: 19841036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4-MD2 Complex.
    Gustavsen A; Nymo S; Landsem A; Christiansen D; Ryan L; Husebye H; Lau C; Pischke SE; Lambris JD; Espevik T; Mollnes TE
    J Infect Dis; 2016 Jul; 214(1):140-50. PubMed ID: 26977050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic CD14 inhibition attenuates organ inflammation in porcine Escherichia coli sepsis.
    Thorgersen EB; Pischke SE; Barratt-Due A; Fure H; Lindstad JK; Pharo A; Hellerud BC; Mollnes TE
    Infect Immun; 2013 Sep; 81(9):3173-81. PubMed ID: 23774598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model.
    Bjerkhaug AU; Granslo HN; Cavanagh JP; Høiland I; Ludviksen JK; Lau C; Espevik T; Mollnes TE; Klingenberg C
    Pediatr Res; 2023 Aug; 94(2):512-519. PubMed ID: 36725909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of
    Keshari RS; Silasi R; Popescu NI; Patel MM; Chaaban H; Lupu C; Coggeshall KM; Mollnes TE; DeMarco SJ; Lupu F
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6390-E6399. PubMed ID: 28720697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood.
    Landsem A; Fure H; Christiansen D; Nielsen EW; Østerud B; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2015 Oct; 182(1):81-9. PubMed ID: 26241501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood.
    Christiansen D; Brekke OL; Stenvik J; Lambris JD; Espevik T; Mollnes TE
    Adv Exp Med Biol; 2012; 946():237-51. PubMed ID: 21948372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood.
    Brekke OL; Waage C; Christiansen D; Fure H; Qu H; Lambris JD; Østerud B; Nielsen EW; Mollnes TE
    Adv Exp Med Biol; 2013; 735():123-36. PubMed ID: 23402023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.
    Taylor FB
    Crit Care Med; 2001 Jul; 29(7 Suppl):S78-89. PubMed ID: 11445739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhibition of complement C5 and CD14 markedly attenuates inflammation, thrombogenicity, and hemodynamic changes in porcine sepsis.
    Barratt-Due A; Thorgersen EB; Egge K; Pischke S; Sokolov A; Hellerud BC; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn M; Scott H; Mollnes TE
    J Immunol; 2013 Jul; 191(2):819-27. PubMed ID: 23761634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post challenge inhibition of C3 and CD14 attenuates Escherichia coli-induced inflammation in human whole blood.
    Egge KH; Thorgersen EB; Lindstad JK; Pharo A; Lambris JD; Barratt-Due A; Mollnes TE
    Innate Immun; 2014 Jan; 20(1):68-77. PubMed ID: 23669326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ inflammation in porcine Escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and CD14.
    Egge KH; Thorgersen EB; Pischke SE; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn MA; Barratt-Due A; Mollnes TE
    Immunobiology; 2015 Aug; 220(8):999-1005. PubMed ID: 25956456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.
    Skjeflo EW; Christiansen D; Landsem A; Stenvik J; Woodruff TM; Espevik T; Nielsen EW; Mollnes TE
    Mol Immunol; 2019 Aug; 112():131-139. PubMed ID: 31102985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis.
    Schöchl H; van Griensven M; Heitmeier S; Laux V; Kipman U; Roodt J; Bahrami S; Redl H
    Crit Care; 2017 Mar; 21(1):51. PubMed ID: 28288667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.
    Sprong T; van der Ley P; Steeghs L; Taw WJ; Verver-Janssen TJ; Netea MG; van der Meer JW; van Deuren M
    Eur Cytokine Netw; 2002; 13(4):411-7. PubMed ID: 12517725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.
    Silasi-Mansat R; Zhu H; Popescu NI; Peer G; Sfyroera G; Magotti P; Ivanciu L; Lupu C; Mollnes TE; Taylor FB; Kinasewitz G; Lambris JD; Lupu F
    Blood; 2010 Aug; 116(6):1002-10. PubMed ID: 20466856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.
    Landsem A; Fure H; Krey Ludviksen J; Christiansen D; Lau C; Mathisen M; Bergseth G; Nymo S; Lappegård KT; Woodruff TM; Espevik T; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2019 Apr; 196(1):97-110. PubMed ID: 30444525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.